article thumbnail

Biotech Roundup: Moonshots, Pink Slips, Gilead, Brexit & More

Xconomy

At the gathering, Biden took verbal shots at scofflaw cancer researchers and at drug prices, while the FDA said it would take a shot at restructuring the way it evaluates oncology products. Gilead Sciences has been a target of drug-price criticism for its hepatitis C treatments, but it dialed back the price of its new one.

article thumbnail

Why Has LA Suddenly Gotten So Much Attention from VCs and Entrepreneurs?

Both Sides of the Table

Over the past decade we’ve had high-profile exits at many companies that pioneered monetization techniques now used across the web including Commission Junction, Value Click, ShopZilla, Price Grabber, LowerMyBills and a newer breed including Invoca, Burstly, Shift, Rubicon Project, Gravity, Convertro, Retention Science and so forth.